JHS

Jubilant HollisterStier Celebrates the Opening of Their Third Manufacturing Line with a Ribbon Cutting Ceremony

Retrieved on: 
Thursday, February 22, 2024

SPOKANE, Wash., Feb. 21, 2024 /PRNewswire/ -- Jubilant HollisterStier held a ribbon cutting ceremony on February 8, celebrating the opening of their third sterile fill finish manufacturing line and the groundbreaking of the next phase of their facility expansion.

Key Points: 
  • SPOKANE, Wash., Feb. 21, 2024 /PRNewswire/ -- Jubilant HollisterStier held a ribbon cutting ceremony on February 8, celebrating the opening of their third sterile fill finish manufacturing line and the groundbreaking of the next phase of their facility expansion.
  • The expansion includes a new high-speed commercial fill finish line, which is part of a 50k sq.
  • At 400 vials per minute, it's equipped with full isolator technology and 100% weight-checking capabilities at production speeds.
  • JHS is currently scheduling time for client projects on the third manufacturing line and has broken ground on Phase 2 of their facility expansion for a fourth manufacturing line.

John H. Snyder PLLC adds Two New Partners to Become Snyder, Hayes & Muchnick LLP

Retrieved on: 
Wednesday, November 1, 2023

NEW YORK, Nov. 1, 2023 /PRNewswire-PRWeb/ -- John H. Snyder PLLC, the Midtown Manhattan-based law and policy firm founded in 2010, is proud to announce the addition of two non-attorney partners, Danny Hayes and Morgan Muchnick. The firm, now known as Snyder, Hayes & Muchnick LLP is focused on legal, finance and policy advisory.

Key Points: 
  • The firm, now known as Snyder, Hayes & Muchnick LLP is focused on legal, finance and policy advisory.
  • Serving as a Registered Lobbyist for the U.S. House of Representatives, he specializes in environmental and energy-related affairs.
  • "Danny Hayes is the most talented and creative dealmaker I have ever met," stated John H. Snyder, the firm's managing partner.
  • Snyder has provided personal counsel to numerous senior executives in sensitive cases and represented heads of state.

"Love Is In The Air"

Retrieved on: 
Friday, September 1, 2023

SAN ANTONIO, Sept. 1, 2023 /PRNewswire/ -- National nonprofit Petco Love, BOBS from Skechers™, and Wings of Rescue joined to evacuate 140+ shelter pets out of Florida to support partner animal welfare organizations in the area after Hurricane Idalia hit the state on Wednesday as a Category 3 hurricane.

Key Points: 
  • Another flight from northern Florida led by Jacksonville Humane Society ("JHS"), includes cats and dogs from JHS and Columbia County shelters, will leave today, Friday.
  • This collaborative effort represents a shared commitment to saving pets lives during times of crisis.
  • "Through purchases of our BOBS from Skechers offering, we have donated $10 million—much of which has supported animals in crisis.
  • Patented image-recognition technology enables the database — populated by more than 2,500 shelter locations — to identify and reunite lost pets.

Jubilant HollisterStier Announces New President and Upcoming Availability of Expanded Production Capacity for Sterile Injectables

Retrieved on: 
Thursday, March 16, 2023

Jubilant HollisterStier (JHS), a leading US-based pharmaceutical contract manufacturer of sterile fill/finish injectables, ampules, ophthalmics and sterile liquid products announces the appointment of Chris Preti as President.

Key Points: 
  • Jubilant HollisterStier (JHS), a leading US-based pharmaceutical contract manufacturer of sterile fill/finish injectables, ampules, ophthalmics and sterile liquid products announces the appointment of Chris Preti as President.
  • Chris Preti has 25 years of varied pharmaceutical experience in research and development, marketing and sales, and operations, including positions of increasing responsibility at Glaxo SmithKline and HollisterStier Allergy, where he was most recently President.
  • As previously announced in May 2022, Jubilant HollisterStier’s expansion plan that is investing ~285 million (USD) to double its capacity for fill and finish of sterile injectables at its Spokane, Washington facility, is progressing well.
  • Chris Preti commented, “This is an exciting time to join Jubilant HollisterStier, as the company continues to expand its capacity to address growing industry demand for the high-quality services we provide.

JOHN HANCOCK INCOME SECURITIES TRUST; JOHN HANCOCK INVESTORS TRUST

Retrieved on: 
Tuesday, February 21, 2023

BOSTON, Feb. 21, 2023 /PRNewswire/ - At their annual meetings held today, shareholders of John Hancock Income Securities Trust (NYSE: JHS) and John Hancock Investors Trust (NYSE: JHI), each a closed-end fund managed by John Hancock Investment Management LLC, elected the following fourteen Trustees to continue to serve as members of the Board of Trustees of JHS and JHI: Andrew G. Arnott, James R. Boyle, William H. Cunningham, Noni L. Ellison, Grace K. Fey, Dean C. Garfield, Marianne Harrison, Deborah C. Jackson, Patricia Lizarraga, Paul Lorentz, Hassell H. McClellan, Steven R. Pruchansky, Frances G. Rathke, and Gregory A. Russo.

Key Points: 
  • BOSTON, Feb. 21, 2023 /PRNewswire/ - At their annual meetings held today, shareholders of John Hancock Income Securities Trust (NYSE: JHS) and John Hancock Investors Trust (NYSE: JHI), each a closed-end fund managed by John Hancock Investment Management LLC, elected the following fourteen Trustees to continue to serve as members of the Board of Trustees of JHS and JHI: Andrew G. Arnott, James R. Boyle, William H. Cunningham, Noni L. Ellison, Grace K. Fey, Dean C. Garfield, Marianne Harrison, Deborah C. Jackson, Patricia Lizarraga, Paul Lorentz, Hassell H. McClellan, Steven R. Pruchansky, Frances G. Rathke, and Gregory A. Russo.
  • Statements in this press release that are not historical facts are forward-looking statements as defined by the United States securities laws.
  • You should exercise caution in interpreting and relying on forward-looking statements because they are subject to uncertainties and other factors which are, in some cases, beyond the Fund's control and could cause actual results to differ materially from those set forth in the forward-looking statements.
  • An investor should consider a Fund's investment objectives, risks, charges and expenses carefully before investing.

Health Foundation of South Florida Invests $2 Million in Florida Universities to Advance Health Equity in Underserved Communities

Retrieved on: 
Friday, February 17, 2023

MIAMI, Feb. 17, 2023 /PRNewswire/ -- The Health Foundation of South Florida, the region's largest philanthropic organization focused on achieving health equity in historically underserved communities, announced it is investing $2 million in two Florida universities to foster research, innovation, community engagement, and leadership development aimed at identifying and addressing barriers to optimal health in low-income communities in Miami-Dade and Broward counties.

Key Points: 
  • UM will partner with Jackson Health System, Miami-Dade County's public hospital, and Health Choice Network, a nationally recognized nonprofit that works with 25 health centers in Florida.
  • The Health Foundation of South Florida Community-Academic Collaborative at the University of Miami will support five community-academic teams charged with developing and implementing data-driven, community-engaged projects to improve health outcomes in underserved communities.
  • "The grant from the Health Foundation provides a unique opportunity for diverse stakeholders to work collaboratively to advance health equity.
  • In addition, the group will build a health equity index and dashboard that enables the monitoring of health equity status in South Florida.

JOHN HANCOCK CLOSED-END FUNDS ANNOUNCE ANNUAL SHAREHOLDER MEETING AND RECORD DATES

Retrieved on: 
Thursday, September 22, 2022

BOSTON, Sept. 22, 2022 /PRNewswire/ - The ten John Hancock closed-end funds listed below announced today that each fund's Annual Meeting of Shareholders ("Annual Meeting") will be held on February 21, 2023, at 2:00 p.m., Eastern Time.

Key Points: 
  • BOSTON, Sept. 22, 2022 /PRNewswire/ - The ten John Hancock closed-end funds listed below announced today that each fund's Annual Meeting of Shareholders ("Annual Meeting") will be held on February 21, 2023, at 2:00 p.m., Eastern Time.
  • The Annual Meeting will be conducted telephonically and there will be no physical location for the Meeting.
  • If you hold your shares through an intermediary, such as a bank or broker, you must register in advance to attend the Annual Meeting.
  • At the Annual Meeting, shareholders of the funds will be asked to elect Trustees of the funds.

Pet Supplies Plus Announces Winner of OptimPlus™ "Feed Great, Feel Great" Sweepstakes and Makes Donation to Deserving Local Pet Shelter

Retrieved on: 
Saturday, August 20, 2022

LIVONIA, Mich., Aug. 20, 2022 /PRNewswire/ -- Supplies Plus, the largest and most trusted pet retail franchise in the United States, launched the addition of OptimPlus™ to their roster of private brand offerings in June. In conjunction with this launch, Pet Supplies Plus sponsored a "Feed Great, Feel Great" sweepstakes for pet parents nationwide with nearly $15,000 worth of prizes.

Key Points: 
  • In conjunction with this launch, Pet Supplies Plus sponsored a "Feed Great, Feel Great" sweepstakes for pet parents nationwide with nearly $15,000 worth of prizes.
  • Twenty-five additional winners nationwide each received a $100 Pet Supplies Plus gift card, a $100 Vitamin Shoppe gift card and a three-month supply of OptimPlus.
  • As part of the new brand launch, Pet Supplies Plus also conducted a nomination-based contest on their social platforms.
  • Pet Supplies Plus offers a wide array of natural pet foods and a variety of made-in-the-USA pet consumables, including food, treats, rawhide and chews.

Jubilant HollisterStier LLC enters into cooperative agreement of $149.6 Mn with US Government to expand critical vaccine manufacturing capacity

Retrieved on: 
Monday, May 30, 2022

Speaking on the announcement, Pramod Yadav, CEO, Jubilant Pharma Limited said,"Jubilant HollisterStier LLC is committed to making the US pharmaceutical supply chain more resilient with domestic manufacturing facilities and less reliant on foreign suppliers.

Key Points: 
  • Speaking on the announcement, Pramod Yadav, CEO, Jubilant Pharma Limited said,"Jubilant HollisterStier LLC is committed to making the US pharmaceutical supply chain more resilient with domestic manufacturing facilities and less reliant on foreign suppliers.
  • We are proud to support the US government in their efforts of making the US more prepared and ready for future pandemics."
  • Jubilant HollisterStier LLC, a subsidiary of Jubilant Pharma Limited, is a leading integrated contract manufacturer of sterile injectables, ophthalmics, optics, sterile and non-sterile topicals and liquids.
  • With facilities in North America, Jubilant HollisterStier LLC provides specialized manufacturing for the pharmaceutical and biopharmaceutical industries.

Jubilant HollisterStier LLC enters into cooperative agreement of $149.6 Mn with US Government to expand critical vaccine manufacturing capacity

Retrieved on: 
Monday, May 30, 2022

Speaking on the announcement, Pramod Yadav, CEO, Jubilant Pharma Limited said,"Jubilant HollisterStier LLC is committed to making the US pharmaceutical supply chain more resilient with domestic manufacturing facilities and less reliant on foreign suppliers.

Key Points: 
  • Speaking on the announcement, Pramod Yadav, CEO, Jubilant Pharma Limited said,"Jubilant HollisterStier LLC is committed to making the US pharmaceutical supply chain more resilient with domestic manufacturing facilities and less reliant on foreign suppliers.
  • We are proud to support the US government in their efforts of making the US more prepared and ready for future pandemics."
  • Jubilant HollisterStier LLC, a subsidiary of Jubilant Pharma Limited, is a leading integrated contract manufacturer of sterile injectables, ophthalmics, optics, sterile and non-sterile topicals and liquids.
  • With facilities in North America, Jubilant HollisterStier LLC provides specialized manufacturing for the pharmaceutical and biopharmaceutical industries.